LT3446B - Fucolsylated glycosides as inhibitor of bacterial adherence - Google Patents

Fucolsylated glycosides as inhibitor of bacterial adherence Download PDF

Info

Publication number
LT3446B
LT3446B LTIP1978A LTIP1978A LT3446B LT 3446 B LT3446 B LT 3446B LT IP1978 A LTIP1978 A LT IP1978A LT IP1978 A LTIP1978 A LT IP1978A LT 3446 B LT3446 B LT 3446B
Authority
LT
Lithuania
Prior art keywords
fucal
alkyl
group
bridge
compound
Prior art date
Application number
LTIP1978A
Other languages
English (en)
Lithuanian (lt)
Inventor
Karin Eklind
Hans Loenn
Anna-Karin Tiden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LTIP1978A publication Critical patent/LTIP1978A/xx
Publication of LT3446B publication Critical patent/LT3446B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
LTIP1978A 1993-06-25 1994-06-27 Fucolsylated glycosides as inhibitor of bacterial adherence LT3446B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93761A DK76193D0 (da) 1993-06-25 1993-06-25 Kulhydratderivater

Publications (2)

Publication Number Publication Date
LTIP1978A LTIP1978A (en) 1995-01-31
LT3446B true LT3446B (en) 1995-10-25

Family

ID=8097261

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1978A LT3446B (en) 1993-06-25 1994-06-27 Fucolsylated glycosides as inhibitor of bacterial adherence

Country Status (9)

Country Link
EP (1) EP0706528A1 (ja)
JP (1) JPH08512026A (ja)
AU (1) AU7089194A (ja)
CA (1) CA2164961A1 (ja)
DK (1) DK76193D0 (ja)
IL (1) IL110074A0 (ja)
IS (1) IS4181A (ja)
LT (1) LT3446B (ja)
WO (1) WO1995000527A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
JPH1160590A (ja) * 1997-08-22 1999-03-02 Yakult Honsha Co Ltd オリゴフコース誘導体又はオリゴラムノース誘導体及びその製造法
SE9901007D0 (sv) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
CA2618638C (en) * 2005-08-09 2014-03-11 Glycomimetics, Inc. Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
CA2858099C (en) 2011-12-22 2020-12-15 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
EP2692740A1 (en) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycan compositions, processes for preparing the same and their uses as a drug
WO2014089269A1 (en) 2012-12-07 2014-06-12 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
MX2015009698A (es) * 2013-01-31 2015-11-06 Pioneer Hi Bred Int Lipoquitooligosacaridos sinteticos para el mejoramiento del crecimiento y el rendimiento de las plantas.
US10086054B2 (en) * 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2016089872A1 (en) 2014-12-03 2016-06-09 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (en) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
US11072625B2 (en) 2016-10-07 2021-07-27 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
CN111566117A (zh) 2017-12-29 2020-08-21 糖模拟物有限公司 E-选择蛋白和半乳凝素-3的异双功能抑制剂
CN111867601A (zh) 2018-03-05 2020-10-30 糖模拟物有限公司 用于治疗急性髓系白血病及相关病症的方法
KR20210057053A (ko) 2018-08-23 2021-05-20 씨젠 인크. 항-tigit 항체
AU2019416330A1 (en) 2018-12-27 2021-07-01 Glycomimetics, Inc. Galectin-3 inhibiting c-glycosides
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603609A (en) * 1977-04-14 1981-11-25 Chembiomed Ltd O-protected 2-azido-2-deoxy-glycosyl nitrates
FR2509313A1 (fr) * 1981-07-08 1983-01-14 Choay Sa Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
DE3220427A1 (de) * 1982-05-29 1983-12-01 Behringwerke Ag, 3550 Marburg Ss-d-galactosederivate, verfahren zu ihrer herstellung und ihre verwendung
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
AU609999B2 (en) * 1988-06-21 1991-05-09 Marion Laboratories, Inc. Bismuth (phosph/sulf)ated saccharides

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
A. R. KATRIZKY: "Handbook of Heterocyclic Chemistry"
AMVAM-ZOLLO PH, SINAY P: "Streptococcus pneumoniae type XIV polysaccharide: synthesis of a repeating branched tetrasaccharide with dioxa-type spacer-arms", CARBOHYDRATE RESEARCH, 1986, pages 199 - 212
D. G. EVANS, D. J. EVANS, JR. GRAHAM, D. Y. G: "Receptor-mediated adherence of Campylobacter pylori to mouse Y-1 adrenal cell monolayers", INFECT. IMMUN., 1989, pages 2272 - 2278
H. H. BAER: "Recent synthetic studies in nitrogen-containing and deoxygenated sugars", PURE APPL. CHEM., 1989, pages 1217 - 1234
HANS PAULSEN: "Advances in Selective Chemical Syntheses of Complex Oligosaccharides", ANGEWANDTE CHEMIE INTERNATIONAL EDITION IN ENGLISH, 1982, pages 155 - 173
J. MARCH, J. WILEY: "Advanced Organic Chemistry - Reaction Mechanisms and Structure", pages: 347 - 389
JOHN H. PAZUR: "Affinity Chromatography of Macromolecular Substances on Adsorbents Bearing Carbohydrate Ligands", ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1981, pages 405 - 447
M.A. JERMYN: "Increasing the sensitivity of the anthrone method for carbohydrate", ANALYTICAL BIOCHEMISTRY, 1975, pages 332 - 335, XP024820798, DOI: doi:10.1016/0003-2697(75)90713-7
M.L. WOLFROM, A. THOMPSON: "Methods in Carbohydrate Chemistry Vol. II", pages: 211 - 215
N. SHARON: "Nomenclature of glycoproteins, glycopeptides and peptidoglycans (Recommendations 1985)", PURE AND APPLIED CHEMISTRY, 1988, pages 1389 - 1988
R. R. SCHMIDT: "New Methods for the Synthesis of Glycosides and Oligosaccharides - Are There Alternatives to the Koenigs-Knorr Method?", ANGEWANDTE CHEMIE INTERNATIONAL EDITION IN ENGLISH, 1986, pages 212 - 235, XP002360565, DOI: doi:10.1002/anie.198602121
RED. T. W. GREENE, P. G. M. WUTS ET AL.: "Protective Groups in Organic Synthesis"
RESEARCH ARTICLE PREV. ARTICLE NEXT: "2-(Trimethylsilyl)ethyl glycosides. 3. Synthesis, anomeric deblocking, and transformation into 1,2-trans 1-O-acyl sugars", J. ORG. CHEM., 1988, pages 5629 - 5647, XP055334967, DOI: doi:10.1021/jo00259a006
STINABRITT NILSSON ET AL.: "Synthesis of an H type 2 and a Y (Ley) glycoside from thioglycoside intermediates", GLYCOCONJUGATE JOURNAL, 1989, pages 21 - 34
Y. C. LEE, R. T. LEE: "Glycoconjugates", pages: 57 - 83

Also Published As

Publication number Publication date
IL110074A0 (en) 1994-10-07
WO1995000527A1 (en) 1995-01-05
DK76193D0 (da) 1993-06-25
CA2164961A1 (en) 1995-01-05
LTIP1978A (en) 1995-01-31
JPH08512026A (ja) 1996-12-17
EP0706528A1 (en) 1996-04-17
IS4181A (is) 1994-12-26
AU7089194A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
LT3446B (en) Fucolsylated glycosides as inhibitor of bacterial adherence
RU2392281C2 (ru) Сульфатированные производные олигосахаридов
JP6028284B2 (ja) 新規硫酸化オリゴ糖誘導体
EP0714903B1 (de) Kohlenhydratkonjugate als Inhibitoren der Zelladhäsion
US7160856B2 (en) α-O-linked glycoconjugates, methods of preparation and uses thereof
EP3197907B1 (en) Vaccines against streptococcus pneumoniae serotype 8
IE860075L (en) Antiviral agents
WO2004058304A1 (en) Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection
US20040219158A1 (en) Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
CZ2001637A3 (cs) Fosfoglykolipidová sloučenina, její pouľití a farmaceutické kompozice ji obsahující
WO2005027936A2 (en) Pharmaceutical compositions and therapeutical treatment with oligo-beta-(1, 3)-glucans
JPH09183789A (ja) 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
CA2954740C (en) Sulfated-glycolipids as adjuvants for vaccines
EP3230297B1 (en) Vaccines against streptococcus pneumoniae serotype 4
JPH09509931A (ja) 胃潰瘍及び十二指腸潰瘍を治療及び阻止する方法
EP0497988A1 (en) Antiviral agent
WO2022106703A1 (en) Protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof
DE10138935B4 (de) Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus
WO2000056343A1 (en) Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
US20220313828A1 (en) Use of low-molecular glycosidically bound terminal galactosides and fucosides for bonding to toxins that act as galectins in the treatment of intoxications, in particular ricin intoxications
CN117651707A (zh) 新的合成的tlr4受体激动剂
JP5283033B2 (ja) シアリルα（２→６）ラクトース含有化合物及びその使用
CA2253913A1 (en) Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
Jiao An anti-Clostridium difficile vaccine: chemical synthesis of the pentasaccharide repeating unit of polysaccharide PS-I
CA2434685A1 (en) Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19960627